subject area of
- Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Journal Articles
- The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies Journal Articles
- When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Journal Articles
- When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Journal Articles